Wegovy (semaglutide) Approval Letter

FDA approved Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.

Not legal or medical advice.

This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.

U.S. Food and Drug AdministrationApproval letterApproved
Docket / Citation
NDA 215256
Published
2021-06-04
Effective
2021-06-04